Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type-Reference-Cited by-同舟云学术

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

Published:2009-08-28 Issue:11 Volume:22 Page:1446-1456
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Torres-Cabala Carlos A,Wang Wei-Lien,Trent Jonathan,Yang Dan,Chen Su,Galbincea John,Kim Kevin B,Woodman Scott,Davies Michael,Plaza Jose A,Nash J W,Prieto Victor G,Lazar Alexander J,Ivan Doina

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2009116.pdf

Reference53 articles.

1. Grichnik JM, Burch JA, Burchette J, et al. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 1998;111:233–238.

2. Grichnik JM . Kit and melanocyte migration. J Invest Dermatol 2006;126:945–947.

3. Holden JA, Willmore-Payne C, Layfield LJ . Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology. Exp Mol Pathol 2008;85:68–75.

4. Alexeev V, Yoon K . Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006;126:1102–1110.

5. Natali PG, Nicotra MR, Winkler AB, et al. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 1992;52:197–201.

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future;Veterinary Sciences;2024-05-02

2. Melanoma biology and treatment: a review of novel regulated cell death-based approaches;Cancer Cell International;2024-02-09

3. Редкие злокачественные опухоли вульвы: клиника, диагностика, подходы к лечению;Malignant tumours;2023-11-22

4. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies;American Journal of Clinical Dermatology;2023-07-03

5. Mastocytosis and Skin Cancer: The Current State of Knowledge;International Journal of Molecular Sciences;2023-06-07